Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients.

Kneteman, N M

Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients. [electronic resource] - Transplantation proceedings Dec 1995 - 3213 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0041-1345


Animals
Cyclosporine--adverse effects
Dogs
Immunosuppressive Agents--adverse effects
Insulin--blood
Islets of Langerhans Transplantation--adverse effects
Polyenes--adverse effects
Sirolimus
Time Factors
Transplantation, Autologous